All Stories

  1. Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?

    Article • Current Vascular Pharmacology, June 2020, Bentham Science Publishers

    Rigas Kalaitzidis, Moses Elisaf

  2. Cardioprotective Properties of HDL: Structural and Functional Considerations

    Article • Current Medicinal Chemistry, June 2020, Bentham Science Publishers

    Moses Elisaf

  3. Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes

    Article • Clinical Pharmacology Advances and Applications, September 2019, Taylor & Francis

    Moses Elisaf

  4. Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects

    Article • Current Vascular Pharmacology, June 2019, Bentham Science Publishers

    Moses Elisaf

  5. Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes

    Article • Disease Markers, March 2019, Hindawi Publishing Corporation

    Moses Elisaf

  6. SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses

    Article • Postgraduate Medicine, February 2019, Taylor & Francis

    Moses Elisaf

  7. Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries

    Article • Current Pharmaceutical Design, January 2019, Bentham Science Publishers

    Evangelos Liberopoulos, Moses Elisaf, Michalis Kostapanos, Mat;ilda Florentin

  8. SGLT-2 inhibitors: pharmacokinetics characteristics and effects on lipids

    Article • Expert Opinion on Drug Metabolism & Toxicology, October 2018, Taylor & Francis

    Moses Elisaf

  9. Uncontrolled Hypertension and Oncology: Clinical Tips

    Article • Current Vascular Pharmacology, December 2017, Bentham Science Publishers

    Moses Elisaf, Rigas Kalaitzidis

  10. Serum Potassium Levels and Mortality in Acute Myocardial Infarction: Myth or Fact?

    Article • Angiology, November 2017, SAGE Publications

    Moses Elisaf

  11. Hyponatremia in the elderly: challenges and solutions

    Article • Clinical Interventions in Aging, November 2017, Dove Medical Press

    Moses Elisaf

  12. Pathophysiology of Diabetic Dyslipidaemia

    Article • Current Vascular Pharmacology, September 2017, Bentham Science Publishers

    Moses Elisaf

  13. Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, August 2017, SAGE Publications

    Moses Elisaf

  14. Serum osmolal gap in clinical practice: usefulness and limitations

    Article • Postgraduate Medicine, March 2017, Taylor & Francis

    Moses Elisaf

  15. Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition

    Article • Current Vascular Pharmacology, January 2017, Bentham Science Publishers

    Moses Elisaf